Combined Use of the Adenosine A 2A Antagonist KW-6002 with l-DOPA or with Selective D1 or D2 Dopamine Agonists Increases Antiparkinsonian Activity but Not Dyskinesia in MPTP-Treated Monkeys

By Kanda T.   Jackson M.J.   Smith L.A.   Pearce R.K.B.   Nakamura J.   Kase H.   Kuwana Y.   Jenner P.  

Experimental Neurology, Vol. 162, Iss. 2, 2000-04 ,pp. : 321-327

Elsevier

Access to resources Recommend Favorite

Cholinergic manipulation of motor disability and l-DOPA-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmosets

By Jackson M.   Swart T.   Pearce R.   Jenner P.  

Journal of Neural Transmission, Vol. 121, Iss. 2, 2014-02 ,pp. : 163-169

Springer Publishing Company

Access to resources Recommend Favorite

Both Short- and Long-Acting D-1/D-2 Dopamine Agonists Induce Less Dyskinesia than l-DOPA in the MPTP-Lesioned Common Marmoset (Callithrix jacchus)

By Maratos E.C.   Jackson M.J.   Pearce R.K.B.   Cannizzaro C.   Jenner P.  

Experimental Neurology, Vol. 179, Iss. 1, 2003-01 ,pp. : 90-102

Academic Press

Access to resources Recommend Favorite

Do Tardive Dyskinesia and l-Dopa Induced Dyskinesia Share Common Genetic Risk Factors? An Exploratory Study

By Greenbaum Lior   Goldwurm Stefano   Zozulinsky Polina   Lifschytz Tzuri   Cohen Oren   Yahalom Gilad   Cilia Roberto   Tesei Silvana   Asselta Rosanna   Inzelberg Rivka   Kohn Yoav   Hassin-Baer Sharon   Lerer Bernard  

Journal of Molecular Neuroscience, Vol. 51, Iss. 2, 2013-10 ,pp. : 380-388

Humana Press, Inc

Access to resources Recommend Favorite

Cortical motor overactivation in parkinsonian patients with L -dopa-induced peak-dose dyskinesia

By Rascol O   Sabatini U   Brefel C   Fabre N   Rai S   Senard JM   Celsis P   Viallard G   Montastruc JL   Chollet F  

Brain, Vol. 121, Iss. 3, 1998-03 ,pp. : 527-533

Oxford University Press

Access to resources Recommend Favorite